Helmholtz Association, Spero Therapeutics deal

Helmholtz Association’s tech transfer partner, Ascenion, granted Spero exclusive rights to develop and commercialize anti-Pseudomonas aeruginosa compounds. Helmholtz is eligible to receive milestone a...